SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-003712
Filing Date
2023-03-14
Accepted
2023-03-14 16:20:17
Documents
39
Period of Report
2023-03-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sgtx-20230314x8k.htm   iXBRL 8-K 43055
2 EX-99.1 sgtx-20230314xex99d1.htm EX-99.1 198422
3 EX-99.2 sgtx-20230314xex99d2.htm EX-99.2 33512
4 GRAPHIC sgtx-20230314xex99d1001.jpg GRAPHIC 5175
5 GRAPHIC sgtx-20230314xex99d2g001.jpg GRAPHIC 91267
6 GRAPHIC sgtx-20230314xex99d2g002.jpg GRAPHIC 321302
7 GRAPHIC sgtx-20230314xex99d2g003.jpg GRAPHIC 94397
8 GRAPHIC sgtx-20230314xex99d2g004.jpg GRAPHIC 167795
9 GRAPHIC sgtx-20230314xex99d2g005.jpg GRAPHIC 207986
10 GRAPHIC sgtx-20230314xex99d2g006.jpg GRAPHIC 106683
11 GRAPHIC sgtx-20230314xex99d2g007.jpg GRAPHIC 117483
12 GRAPHIC sgtx-20230314xex99d2g008.jpg GRAPHIC 145221
13 GRAPHIC sgtx-20230314xex99d2g009.jpg GRAPHIC 187690
14 GRAPHIC sgtx-20230314xex99d2g010.jpg GRAPHIC 150534
15 GRAPHIC sgtx-20230314xex99d2g011.jpg GRAPHIC 161795
16 GRAPHIC sgtx-20230314xex99d2g012.jpg GRAPHIC 100267
17 GRAPHIC sgtx-20230314xex99d2g013.jpg GRAPHIC 155162
18 GRAPHIC sgtx-20230314xex99d2g014.jpg GRAPHIC 126750
19 GRAPHIC sgtx-20230314xex99d2g015.jpg GRAPHIC 143715
20 GRAPHIC sgtx-20230314xex99d2g016.jpg GRAPHIC 165228
21 GRAPHIC sgtx-20230314xex99d2g017.jpg GRAPHIC 162125
22 GRAPHIC sgtx-20230314xex99d2g018.jpg GRAPHIC 157736
23 GRAPHIC sgtx-20230314xex99d2g019.jpg GRAPHIC 196676
24 GRAPHIC sgtx-20230314xex99d2g020.jpg GRAPHIC 177767
25 GRAPHIC sgtx-20230314xex99d2g021.jpg GRAPHIC 118151
26 GRAPHIC sgtx-20230314xex99d2g022.jpg GRAPHIC 139349
27 GRAPHIC sgtx-20230314xex99d2g023.jpg GRAPHIC 120132
28 GRAPHIC sgtx-20230314xex99d2g024.jpg GRAPHIC 35908
  Complete submission text file 0001558370-23-003712.txt   5323974

Data Files

Seq Description Document Type Size
29 EX-101.SCH sgtx-20230314.xsd EX-101.SCH 2951
30 EX-101.LAB sgtx-20230314_lab.xml EX-101.LAB 16579
31 EX-101.PRE sgtx-20230314_pre.xml EX-101.PRE 10453
33 EXTRACTED XBRL INSTANCE DOCUMENT sgtx-20230314x8k_htm.xml XML 5047
Mailing Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142 617-336-7540
Sigilon Therapeutics, Inc. (Filer) CIK: 0001821323 (see all company filings)

IRS No.: 474005543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39746 | Film No.: 23731280
SIC: 2834 Pharmaceutical Preparations